BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Drug Development

  Emergent BioSolutions Release: New Studies Conclude BioThrax(R) Plus Antibiotics Provide 100% Protection In Animals When Administered After Anthrax Exposure

  January 10, 2006

   · 

  2 min read
• Drug Development

  BiovaxID(TM), Personalized Anti-Cancer Vaccine From Biovest International, Inc., Produces Long Term Clinical Remission And 95 Percent Overall Survival In Patients With Follicular Non-Hodgkin’s Lymphoma In Phase 2 Clinical Trial

  January 10, 2006

   · 

  1 min read
• Business

  Elan Pharmaceuticals And EntreMed, Inc. Execute License Agreement For Proprietary NanoCrystal(R) Technology

  January 10, 2006

   · 

  6 min read
• BioMidwest

  Journal Article Says Zimmer Holdings Inc. Minimally Invasive Knee Replacement Procedure Generates Significant Hospital Profitability Per Medicare Patient

  January 10, 2006

   · 

  6 min read
• Biotech Beach

  Smiths Medical MD, Inc. Launches New Gravity Administration Set

  January 10, 2006

   · 

  2 min read
• Drug Development

  AVI BioPharma, Inc. Reports Favorable Safety And Pharmacokinetic Data From Its Clinical Trial Targeting Hepatitis C Virus

  January 10, 2006

   · 

  1 min read
• Business

  ePocrates Collaborates With Massachusetts General Hospital To Offer Unique Decision Support Tool

  January 10, 2006

   · 

  3 min read
• Business

  Ventegra(SM) Names Pharmacy Industry Expert Alex Gilderman, Pharm.D, Vice President, Clinical Programs

  January 10, 2006

   · 

  1 min read
• Business

  Amgen Announces Webcast Of 2005 Fourth Quarter And Full Year Financial Results

  January 10, 2006

   · 

  1 min read
• Business

  Human Genome Sciences, Inc. Receives Milestone Payment From GlaxoSmithKline For Filing Of GSK716155 IND Application To Begin Phase 1 Trials In The Treatment Of Diabetes

  January 10, 2006

   · 

  4 min read